Related content

Response to Chiasson et al.: Acarbose for the prevention of Type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data

By Sawicki P.   Kaiser T.  

Diabetologia, Vol. 47, Iss. 6, 2004-06 ,pp. : 976-977

Springer Publishing Company

Access to resources Recommend Favorite

Acarbose for prevention of diabetes, hypertension and cardiovascular events? A critical analysis of the STOP-NIDDM data

By Kaiser T.   Sawicki P.  

Diabetologia, Vol. 47, Iss. 3, 2004-03 ,pp. : 575-580

Springer Publishing Company

Access to resources Recommend Favorite

2009 SIPREC Consensus Document - Executive Summary: Cardiovascular Prevention in Subjects with Impaired Fasting Glucose or Impaired Glucose Tolerance

By Volpe Massimo   Borghi Claudio  

High Blood Pressure & Cardiovascular Prevention, Vol. 17, Iss. 4, 2010-12 ,pp. : 237-247

Adis International

Access to resources Recommend Favorite

Common polymorphisms in the genes regulating the early insulin signalling pathway: effects on weight change and the conversion from impaired glucose tolerance to Type 2 diabetes.: The Finnish Diabetes Prevention Study

By Laukkanen O.   Pihlajamäki J.   Lindström J.   Eriksson J.   Valle T.   Hämäläinen H.   Ilanne-Parikka P.   Keinänen-Kiukaanniemi S.   Tuomilehto J.   Uusitupa M.   Laakso M.  

Diabetologia, Vol. 47, Iss. 5, 2004-05 ,pp. : 871-877

Springer Publishing Company

Access to resources Recommend Favorite

Serum levels of proamylin and amylin in normal subjects and patients with impaired glucose regulation and type 2 diabetes mellitus

By Zheng Xiaoya  

Acta Diabetologica, Vol. 47, Iss. 3, 2010-09 ,pp. : 265-270

Springer Publishing Company

Access to resources Recommend Favorite